Results 181 to 190 of about 3,074 (210)

Torsemide-Induced Pseudoporphyria

Archives of Dermatology, 2008
Alicia Pérez-Bustillo, Pedro Sánchez-Sambucety, Óscar Suárez-Amor, Manuel Angel Rodríiguez-Prieto   +3 more
openaire   +1 more source

In Brief: A New Torsemide Formulation (Soaanz) for Edema

The Medical Letter on Drugs and Therapeutics
The FDA has approved Soaanz (Sarfez), a new formulation of the loop diuretic torsemide, for treatment of edema associated with heart failure or renal disease in adults. Torsemide has been available generically for years for treatment of hypertension and treatment of edema due to heart failure, renal disease, or hepatic disease.
openaire   +2 more sources

Torsemide

Reactions Weekly, 1997
openaire   +1 more source

Torsemide

2012
William G. Cioffi, Michael D. Connolly, Charles A. Adams, Mechem C. Crawford, Aaron Richman, William H. Shoff, Catherine T. Shoff, Suzanne M. Shepherd, Benjamin S. Abella, Thomas H. Cogbill, Stefan De Hert, Christiaan Keijzer, Toby M. Enniss, J. Wayne Meredith, Sacha Zeerleder, Sacha Zeerleder, Kenneth L. Mattox, Frederick Fiesseler, Richard D. Shih, Marina S. Morgan, Edmund Ong, Nikhil Premchand, Gregory W. Fischer, Edmond Cohen, Robert S. Green, Donald Griesdale, Christian Byhahn, Charles G. Durbin, Gregory J. Jurkovich, Marcus J. Schultz, Ognjen Gajic, Richard J. Mullins, Christian A. Hamlat, Ronald V. Maier, Christian A. Hamlat, Ronald V. Maier, E. Mark Hammerberg, Raeanna C. Adams, Oliver L. Gunter, John A. Morris, David K. Menon, Jordan Bonomo, Edgardo S. Salcedo, Jose L. Pascual, Philip F. Stahel, Michael A. Flierl, Brittany Matava, David C. Cone, Rui P. Moreno, Susan M. Lareau, Richard H. Beigi, Stefan Herget-Rosenthal, Keri A. Cohn, Sarah L. Wingerter, Lise E. Nigrovic   +54 more
openaire   +1 more source

An evaluation of torsemide in patients with heart failure and renal disease

Expert Review of Cardiovascular Therapy, 2022
Anthony E Peters, Mentz Rj, Stephen J Greene   +2 more
exaly  

Torsemide Tablets

2021
openaire   +1 more source

Stability of torsemide in 5% dextrose injection

American Journal of Health-System Pharmacy, 1998
P A, Montgomery, L A, Cornish, C E, Johnson, K A, Fitzpatrick   +3 more
openaire   +2 more sources

Torsemide Compounded Oral Suspension

2023
openaire   +1 more source

Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients

Biomedicine and Pharmacotherapy, 2023
Xin Hai
exaly  

Interaction of torsemide with native cyclodextrin through inclusion complexation: In-vitro drug release, antibacterial and antibiofilm activities

Journal of Molecular Structure, 2023
rajaram Rajamohan, Yong Rok Lee, Thambusamy Stalin   +2 more
exaly